Essilor Instruments
Making its debut at 100% Optical was the WRI-1 Cellview retinal imaging system, which produces high resolution, true colour ultra-widefield retinal images with up to a 200° view.
The device produces images of 133° in a single-capture, or a 200° auto-stitched image for a wider view of the retina, where certain pathologies and conditions can sometimes go unnoticed. Detection and management of vision threatening conditions such as diabetic retinopathy, macular degeneration and glaucoma are all possible with the WRI-1 Cellview. Imaging through pupils as small as 2.5mm can allow for reduced chair time by eliminating the need for dilating many patients. Images can also be acquired through cataracts and other media opacities.
Paul Cumber, instruments director at EssilorLuxottica, told Optician: ‘Further to enhanced patient care, it has a long list of advantages to help grow an optical practice including reduced chair time, increased practice workflow, and peace of mind for the patient and practitioner.’
The system also includes remote data access through a web browser and patient data review, and unlimited cloud storage of patient data and images. In addition, the WRI-1 features infrared imaging and imaging tools to aid the practitioner in their analysis of the fundus.
Optos
New from Fife-based Optos was MonacoPro, its latest evolution of next-generation ultra-widefield scanner laser ophthalmoscope (SLO) and spectral domain retinal imager.
The new machine brings several performance upgrades, says the company. Improved image quality and detail that meet the needs of the most demanding eye care practices, allows practitioners to visualise and analyse retinal layers with greater accuracy to support diagnosis and treatment planning. 
When combined with the integrated 200° single-shot optomap imaging, MonacoPro increases the identification of macular pathology by 29.4% compared with fundus imaging alone.
A new software tool to improve imaging workflow efficiency has also been introduced. AreaAssist enables users to automatically measure continuous areas of matching colour and adjust the sensitivity of the selected area with a click and drag of the mouse.
By automating and simplifying these processes, Optos says the need for time-consuming manual tasks, allowing practitioners to focus on patient care and clinical decision-making.
Lastly, the new device can tap into a larger Optos reference database, which now includes 879 eyes and stratifies based on different optic disc sizes in addition to age. Optos says this is a more effective approach than other criteria for identifying relevant population data, leading to greater diagnostic precision.
Topcon
One of the most anticipated launches on the Topcon stand was the newly CE marked eye-light photobiomodulation device from Italian manufacturer, Espansióne Group.
The company says the launch marks a new era in providing ophthalmology applications of light-based technologies, and is set to change the landscape for both patients and practitioners, with the new CE certification representing a significant opportunity in the non-invasive management of dry age-related macular degeneration (AMD).
Matteo Corbellino, executive board member and chief marketing and innovation officer at Espansióne Group, said: ‘This outstanding milestone is a testament to the team’s relentless focus on clinical development and the strong bond we share with the broader research community, for which we’re deeply thankful – without it, this achievement would never have been possible.’
Fergal Byron, senior technical products manager at Topcon, added: ‘The addition of the eye-light device for treating dry AMD integrates perfectly with Topcon’s comprehensive product portfolio. This enables us to provide not only advanced diagnostic tools for detecting and monitoring AMD but also an innovative, non-invasive treatment solution, supported by robust clinical evidence.’
BIB Ophthalmic Instruments
For several years now, Optopol’s Revo OCT devices have been a popular and more cost-effective alternative to some of the household imaging names. The new HR iteration of the Revo launched at the event by distributor BIB Ophthalmic Instruments includes several
performance upgrades, with enhanced axial length measurement and new myopia management software, artificial intelligence (AI) segmentation and a new ultra-widefield scanner.
A Myopia Forecast module opens progression of the ocular structure parameters according to trends over population mode. Usage reference based on research from multiple universities along with environmental factors allow the monitoring of changes from childhood to adolescence.
New AI layer segmentation for the posterior segment results in more accurate recognition of retinal layer boundaries, says the company. It adds that the AI system has a direct impact on the accuracy of the clinical assessment and the assessment of the status of areas of pathology in the retina.
Mainline Instruments
Fresh from agreeing a distribution deal just weeks before 100% Optical, Mainline Instruments was able to have the Envision suite of non-surgical dry eye treatments from InMode.
The compact, programmable Envision workstation is designed for customisable treatments in optometric practices. The system uses three complementary modes of treatment with small applicators to target delicate subdermal layers in the periorbital area, offering what Mainline Instruments said was a holistic approach to treating dry eye.
The Lumecca-I module delivers intense pulsed light (IPL) to reduce the vascular inflammation to treat dry eye/ocular surface disease, offering precision and targeted spot-size treatments through a tailored adaptor.
Forma-bipolar radiofrequency (RF) thermal technology has been designed to deliver targeted RF energy to small, delicate zones, such as the periorbital area, targeting the meibomian glands to support effective dry eye treatment and improve the quality of meibum.
In addition, it was said to improve the aesthetic outcome by promoting collagen to help rejuvenate the periorbital area.
Fractional skin treatment, Morpheus8, stimulates the underlying layers of the dermis. By targeting the deeper layers of the skin, tissues are triggered to create a more youthful appearance. The company says RF energy is a scientifically proven method to stimulate collagen. It is minimally invasive, using a matrix of micro pins to target the deeper layers of the skin with almost no patient downtime.
Birmingham Optical/Ibis Vision
One of the many new products on the Birmingham Optical stand was the Volk Viva portable fundus camera. The device’s key strength is
its flexibility, as it can be used in practice and domiciliary settings, as well as by all practice staff. Images can be captured in less than a minute, thanks to sophisticated alignment tracking and a simple operator interface.
Workflow is similar to that of a smartphone and annotations and colour filters can be added to detailed reports with a few clicks. Reports can be easily shared, which the company says enhances efficiencies in billing, consultations and referrals.
Sharing the Birmingham Optical stand was Scottish digital vision testing software developers, Ibis Vision, which used the event to launch its latest platform, CheckMy.Vision.
The platform, which brings the company’s IBISrecheck technology, offers optometrists pre-visit insights into the patient’s vision before they enter the practice. Ibis Vision says this streamlines patient care, reduces wait times and enhances personalised experience.
In addition, the platform can be white labelled to match practice websites for better integration.
